Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
Bristol-myers' stock extends slide after downgrade MRK upgraded #news #market https://t.co/SqfgygRTZ2
The MRK Manual Home Health Handbook by E. MRK (2011, Paperback) https://t.co/D4gQ4CRHTy https://t.co/XwuvQXGdji
Results from MRK's Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients ...: K... https://t.co/mOAmuYNbyv #pharma
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/zKU0MnjjQ8 $MRK
#MRK & Co. Stock Rating Reaffirmed by Piper Jaffray Cos. Read more: https://t.co/MXgzlkZJ7j $MRK
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/XA34rBQH6q $MRK
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/GSB7dx9cfA $PJC
MRK & Co. (MRK) Rating Reiterated by #PiperJaffray Cos. Read more: https://t.co/zIl8c94Xfs $PJC
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/16gprw4CmQ $PJC
#MRK & Co. Rating Reiterated by Piper Jaffray Cos. Read more: https://t.co/PbHad0VfIb $MRK
MRK & Co. (MRK) Stock Rating Reaffirmed by #PiperJaffray Cos. Read more: https://t.co/7h243l3Jhs $PJC
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/iMxN87DlFe
MRK Has Some Explaining To Do Over Its MMR Vaccine Claims https://t.co/QO4T8Mkl6o
US clears MRK's Keytruda for head and neck cancer https://t.co/QPzXgdlLqt
#AnimalPharm  MRK introduces Safe-Guard AquaSol to US pigs https://t.co/tAL4ucCplp
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/PbAJUvZR4Z $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/bSnBaP7DKz $CS
Why #CreditSuisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/9CXArovHrp $CS
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/WCHMeuE4qG $BMY
#BristolMyersSquibb Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further. Read more: https://t.co/xYw7gXNIuQ $BMY
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment #lymphocytes https://t.co/ncHz5KFpv7
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma $mrk https://t.co/dT6ac2L6C8
$MRK: MRK announces the publication of results from C-EDGE CO-STAR, a Phase 3 trial evaluating the use of... https://t.co/FpThhpcMOk
$MRK MRK soars, $BMY Bristol-Myers tumbles on Opdivo fail in first-line #NSCLC https://t.co/XHlft009Uc via @FierceBiotech
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/cDoERWnsB8
#Cambridge #Job Immunology Scientist Job: Immunology  Scientist-RES001620DescriptionThe  MRK  Research  Lab... https://t.co/We3f4pBMUj
#Cambridge #Job Microbiome Lead Job: Microbiome  Lead-RES001621DescriptionThe  MRK  Research  Laboratories ... https://t.co/5bx7cXCCD7
#Cambridge #Job Microbiome Scientist Job: Microbiome  Scientist-RES001618DescriptionThe  MRK  Research  Lab... https://t.co/9EihugR5DU
Is our species transcending our economy to develop cures for chronic diseases @pfizer @MRK @Novartis @sanofi @GSK_bio? #Philosophy #Health
Biotech Search Engine : https://t.co/JJvQnue8tK #biotechnology #biofinder : #Biotech Results from MRK’s Phase 3… https://t.co/nngDrAM2PE
#biotech #science Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patie... https://t.co/N3CfgV0pAe
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/eNJgZ7oEF5
#biotechnology Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients... https://t.co/uSVWSOYVqi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients wit... https://t.co/CH53vLtXpP #biofinder
#Biotech Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with ... https://t.co/rT6RooXRWW
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with C... https://t.co/xvglkJGHQj #pharma
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High via @forbes https://t.co/iJd4USyKuE
#Opdivo bet backfires, creates opening for MRK to pursue #DTC. $BMY $MRK #pharma #hcmktg https://t.co/OkA9F8wfBz https://t.co/F1Cp1iLvpz
Empowering Infertile Women! MRK Healthcare supports women with the “MRK More than A Mother” Initiative | Watch V…https://t.co/J6EdTu9jWQ
Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/4j3OWk68Tu
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/ahrAp3igA2
The MRK Manual of Medical Information (2004, Paperback, Revised) https://t.co/IcpZ4oVLlM https://t.co/VBGpauxulq
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/KTokmF4Si2
FDA Approves #MRKs KEYTRUDAÂ pembrolizumab for Patients with       Recurrent or Metastatic... Read more: https://t.co/JsxdS0Ujvg $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/wbEjrgNZAN $MRK
FDA Approves #MRK & Co.???s KEYTRUDA (Pembrolizumab) For Patients With Recurrent Or Metast... Read more: https://t.co/lg5hcz0kOA $MRK
AAPL, MRK And These 3 Stocks Can Lead The Dow To Yet Another New High https://t.co/BzzeGwrgRF
#MRKs Keytruda Wins FDA Approval for Treatment of Patients with Head and Neck Cancer. Read more: https://t.co/1dtnAuuZtJ $MRK
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic Hepati… https://t.co/zI0S8tQs5p
https://t.co/Kpovo0FxNa MRK more than a mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/XfP8djAmlp
https://t.co/p1BhlI2WFl MRK more than a Mother empowers infertile women in Africa so no other woman should suffer the same way Jackeline…
https://t.co/wnbbOvIDsk MRK more than a Mother empowers infertile women so no other woman should suffer the same way Jackeline Mwende did.
MRK More Than A Mother - High level panel calls for Action, Finland https://t.co/qrG92rI1tF
@ShimminyKricket @DutchieFlair the compounds and extracts can be patented that's how MRK and Pfizer survive, not the herb itself
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: Through “Empow... https://t.co/WaEWprNgfV
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/Eh6FNXy8Wz
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/rkVIDsjKv5
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/519MiyqvPV
#MRK MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and R... Read more: https://t.co/6VPjVX8MCP $MRK
APO - “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya: “MRK M... https://t.co/dPuXgT3xri
We are so grateful to the MRK employees who came out today to help us put together Welcome Bags for school... https://t.co/wnMxpsrsnH
Pembrolizumab gained FDA's approval in head & neck squamous cell carcinoma
https://t.co/yGEzm0Stbx via @biopharmadive
@MRK Varivax has aborted fetal cell line in production. don't want remote cnxn w/ murder - won't give to son. Please make ethical version!
From @skepticalraptor @doritmi https://t.co/QlpI0Y8GSD #CDCwhistleblower #hearthiswell #whyivax #iamtheherd #vaccineswork
FDA gives approval for MRK's PD1 inhibitor following BMS Nivo for SCCHN

https://t.co/QMCheKPV0U

#SCCHN #PD1 #MRK #Ketryuda #approval
MRK PD-1 inhibitor Ketryuda gets approval in head and neck Tumors.

https://t.co/egCP1ZK9VX

#MRK #ketryuda #PD1 #SCCHN #approval
Have you seen our latest #HCV news? Click here: https://t.co/dgCuJgCBUO
.@MRK: Age, presence of toxin B antibodies influence C. difficile recurrence https://t.co/2YcUEstNxB
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/CHCIWZud5V
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/L3BCQRtqF2
MRK locks up another cancer approval for Keytruda https://t.co/td1EgbWi2t via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/L6PSgiG6Kq via @biopharmadive
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/528YiPb99j via @biopharmadive
MRK locks up another cancer approval for Keytruda https://t.co/S9DUhXj4pv via @biopharmadive
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chronic… https://t.co/25J3IpCbPM
More good news about MRK's Keytruda: MRK locks up another cancer approval for Keytruda https://t.co/qNLyJBocV7 via @biopharmadive
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/1JriIebBWC
MRK & Co. Boost Price Target by Deutsche Bank (Ranked 16th) to $59 as Hold $MRK #MRK https://t.co/mlEp5x7TLi
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/65pY5e9rMX #biotech #biotech
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/n25MUO9brX https://t.co/9ta32g48V7
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients… https://t.co/I04IEgjcy1 #science #science
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in… https://t.co/ArXgF6e3Pd https://t.co/ZRr81K79pK
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with Chro... https://t.co/LJY3pLHQmg
More good news about MRK's Keytruda helping people with Head-and-Neck Cancer fight the battle. https://t.co/sWeMQowNKx
Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients with… https://t.co/CIH7Mya2Uf #pharma #pharma
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/Hv1CCx9WXc
More good news about Keytruda: MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/zgDb5JuuTc
$MRK:

Results from MRK’s Phase 3 Study Evaluating ZEPATIER …:

https://t.co/6wxadffuqc
$MRK Results from MRK’s Phase 3 Study Evaluating ZEPATIER™ (elbasvir and grazoprevir) in Patients w... - https://t.co/Ri7EujrWur
More good news about MRK's Keytruda now approved to help patients with Head-and-Neck Cancer fight the battle. https://t.co/EBQrMX1JR8
Contact us if you suffered serious side effects or lost a loved one after vaccination with MRK shingles vaccine.   rmatthews@dmlawfirm.com
MRK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) //channels.feeddigest…
#BioSpace  FDA Approves MRK and Co.s KEYTRUDA (Pembrolizumab) For Patients With https://t.co/hwjHD0SHHP
MRK's blockbuster drug Keytruda approved to treat head and neck cancer - Becker's Hospital Review https://t.co/CzxUgBohIP via Black Swan…
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/XuVY96t6cu via @FiercePharma
2004 Whitetail Deer Old World Christmas Blown Glass Ornament 121622 MRK Family https://t.co/Q1OnWn0vqM https://t.co/wwCvzrLB5m
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/fho0COkAe5
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/OuCCY3LFgO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/z1VAjr6GyO
MRK's blockbuster drug Keytruda approved to treat head and neck cancer https://t.co/7uuUzewTbM
Info Animal health companies focus on vaccines as VFD regs are implemented: Zoetis, MRK Animal Health and E... https://t.co/BrwfnEJQpM
CAR MAGNET UPDATE: the SMOW magnet was put back so JOKES ON YOU I HID ALL MY MAGNETS SO YOU CANT PULL THIS SHIT AGAIN
@MRK's Keytruda wins a double-header with new @US_FDA approval in head-and-neck cancer https://t.co/UEAgpADKNC
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/tt5GQG4BeN
MRK’s response was to repackage the chicken pox vaccine as Zostovax and make it some 14 times stronger.     rmatthews@dmlawfirm.com
FDA approves MRK's KEYTRUDA for recurrent or metastatic HNSCC https://t.co/niDSmtfIZn
 #healthinnovations #pharma #health #fda #legal
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/HaL4JaRA2a
#BigMoleculeWatch.com:  FDA Accepts MRK’s Lantus Biosimilar for Review https://t.co/g5oq0onRSt
‘MRK More than a Mother’ supports Jackline Mwende, victim of Infertility stigma in Kenya https://t.co/EPMr760COA
Bristol-Myers shares are bombing after a failed study — and its biggest rival is surging #bristolmyers   #MRK #crownfinancialpartners
Accelerated Approval of Keytruda® (MRK) for Head & Neck Cancer @hncalliance @US_FDA @MRK @oralcancerfnd https://t.co/fn5sRiE106
Need a Lyft coupon code? Here's one for $50 LyftOfferCode OATH >>> Passion for MRK & Co.?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | ... https://t.co/kWLLY8dWc5 https://t.co/P9X94LTabn
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/ummVacXvQJ
MRK announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine https://t.co/e29laoRQSw
#Pharmaceuticals FORTZAAR : Tablet, film coated : 100/25mg : MRK and Co USA : https://t.co/Cywp48KvYe #MarketResearch #Statistics
MRK More than a Mother supports Jackline Mwende - a Victim of… https://t.co/4n7sWImOW6 #GhanaNews #Ghana
@Vaccin8tionNews @icansketchu by not explaining @MRK has made it a huge deal, it's in prescribing info and should be clearly explained
TwitterText Polyps of the Cervix - Women's Health Issues - MRK Manuals Consumer Version https://t.co/IhxRyTeevM via @MRKManualHome
@MRY_ivy @doritmi @itsmepanda1 @dkegel @ParentAlerte @vaxchoiceeast People dropping like flies... MRK said "shit happens". Same with vax.
To sell the shingles vaccine, MRK displays shingles problems on its web site.   rmatthews@dmlawfirm.com
MRK Hiring 2016 & 2017 HBCU Grads - Register For This Special Opportunity! https://t.co/3EsJULF4ev
FDA Grants Accelerated Approval for Keytruda in HNSCC: MRK announced that the Food and Drug Administration ... https://t.co/DivwXBt27H
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya: ldquo;MRK More... https://t.co/a71VrFnRoJ
#Pharmaceuticals ISENTRESS : Tablet, film coated : 400mg : MRK & Co Inc : https://t.co/HYXwqRkQrZ #MarketResearch #Statistics #mrx
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/3EQCWxmmO9
The Dow Jones industrial average fell 36 points, or 0.19 percent, to 18,509, with MRK leading decliners and... https://t.co/5p1lVlM3Zw
MRK sells  its shingles vaccine in this same old fashioned way, by selling the disease.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/HnbmWC1bhs
Bristol-Myers' stock extends slide after downgrade, MRK upgraded https://t.co/yeV6vOLDWb
MRK's vaccines are no better. They disable, maim, and kill. https://t.co/Qsh8qYdaIi
$MRK's Keytruda wins approval in HNSCC, putting pressure on $BMY Opdivo after trial miss https://t.co/WUGI3Lkip0
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/QQdxgIwfb2 $BMY
#BristolMyersSquibb Bristol-Myers' stock extends slide after downgrade, MRK upgraded. Read more: https://t.co/SoDQehZ6vA $BMY
MRK & Co. (MRK) PT Raised to $57.00 at #Jefferies Group. Read more: https://t.co/dkCmfXhwOc
@taylor_MRK Are you okay, bb?
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/Zi6ZTudILO $MRK
@MRK_Engage silver today
#MRK & Co. PT Raised to $57.00 at Jefferies Group. Read more: https://t.co/iGD3yjksfN $MRK
“MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya - DEWJIBLOG https://t.co/2XcDjfAeku
@Vaccin8tionNews @icansketchu MRK refuses 2tell me what "it" is which is what makes it so disturbing Y not use measurements like we all do
MRK also produced Vioxx, the four-dollar aspirin that caused thousands of people heart attacks and strokes.     rmatthews@dmlawfirm.com
#Opdivo and #Keytruda set for India launches by end of year @MRK @bmsnews https://t.co/t2Wa0Z8m18
#PressTZ “MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/GccZXuEGcB
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer $MRK! via @FiercePharma https://t.co/TaEtX5lE9o
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/gl6quH0zqu $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, #Pfizer and Procter & Gamble. Read more: https://t.co/kgNXxxMo4L $PFE
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/oIvWxEp7c5 $CVX
The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, #MRK, Pfizer and Procter & Gamble. Read more: https://t.co/3Gfu5gPJRg $MRK
The Zacks Analyst Blog Highlights: ExxonMobil, #Chevron, MRK, Pfizer and Procter & Gamble. Read more: https://t.co/IPlrFYp3aU $CVX
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/zkMsTrxsyh $XOM
#ExxonMobil The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, MRK, Pfizer and Procte... Read more: https://t.co/p6LgnWZfRm $XOM
A MRK whistleblower recently explained that the company faked measles vaccine data in order to retain lucrative government contracts.
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/O5tuquO1qs $MRK
Allergan CEO says company "doesn't need" a big acquisition, a week after @WSJ reported Allergan & MRK eyed Biogen. https://t.co/Mj4L0tlHao
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/UTn2uY5mQn $MRK
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/PPnLJqqvpt $AZN
#AstraZeneca Citi Doesn't See MRK's Lung Cancer Success Lasting Long - MRK & Company, In... Read more: https://t.co/5oM2bEoN1l $AZN
Citi Doesn't See #MRK's Lung Cancer Success Lasting Long - MRK & Company, Inc. (NYSE:), ... Read more: https://t.co/5DKy6ZIaxD $MRK
#MRK & Co.  Shares Down 1.8%  After Insider Selling. Read more: https://t.co/lhePUWK3Or $MRK
$MRK: Analyst action by Deutsche Bank on MRK & Co: https://t.co/im57bhmX9g https://t.co/Lwh57GOLmZ
It’s helpful to keep in mind that MRK also produced the ill-fated Gardisil vaccine.   rmatthews@dmlawfirm.com
There is, at least, a shingles vaccine in name, according to MRK Pharmaceuticals, the company that makes it.
.@MRK files Lantus #biosimilar with @US_FDA https://t.co/2DT6P6xvCR
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/13Y5S5YebC $MRK #MRK
MRK & Co. $MRK Rating Reiterated by Piper Jaffray Cos. https://t.co/3mkldA0IEW
“MRK More than a Mother” supports Jackline Mwende – a Victim of Infertility Stigma in Kenya https://t.co/1BdoVtfNCp
@EMcCra2 @lizditz they all show themselves up really nobody believes them now we are the credible one's they are crazies defending MRK
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain https://t.co/U0An1VU9am
$MRK - MRK & Co. #MRK Stock Rating Reaffirmed by Piper Jaffray Cos. https://t.co/vqnyqHktS5
MRK  & Co.'s neutral rating reiterated at Piper Jaffray Cos.. $62.00 PT. https://t.co/LGnAxRpsbY $MRK #MRK
I like that MRK commercial during the Olympics that says if you don't buy their vaccine, your kids will get cancer & its your fault.
@MorningstarInc Investors #MRK Could Gain from Bristol's Poor Drug Trial Results https://t.co/ppzAdaPJ5g $BMY $MRK https://t.co/mMbBOYAOrg
Technical Alert: MRK Surrenders Some Of Friday's Huge Gain: 
$63.86 - Friday close

$63.02 - Intraday h... https://t.co/OKMBHMVMPZ
MRK’s shingles vaccine has some problems.   rmatthews@dmlawfirm.com   1.608.448.4313
#APO “MRK More than a Mother” supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/5mOZJ2QRuP
Contact us for a free legal consultation if you suffered serious side effects or lost a loved one after vaccination w/MRK shingles vaccine
MRK & Co. Upgrade by Credit Suisse (Ranked 26th) to Outperform $MRK #MRK https://t.co/mlEp5x7TLi
But big Pharma experts report MRK is working on non-live form of virus which is meant to keep those vaccinated with...
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/fjHzEthX1q
According to MRK Pharmaceuticals, Zostavax contains a “weakened” or  “attenuated” form of the virus;...
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/ZJd8HDfFVM
clayton: MRK 63.11 MRK & Company $MRK added to my watch https://t.co/dlV5mlLAeP
The vaccine MRK makes is virtually the same, except that the shingles vaccine is some 14x stronger than the chickenpox version.
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/IP0sFs5bBb
Nevertheless, it is fair to ask if the risk-reward of MRK’s shingles vaccine is worth one’s taking the shot.
US clears MRK’s Keytruda for head and neck cancer https://t.co/TZzLnWnfed
$MRK locks up another cancer approval for Keytruda, putting pressure on $BMY https://t.co/WUGI3Lkip0
Why MRK’s Lung Cancer Success Won’t Last https://t.co/X1JKFeBaqp via @barronsonline
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/OanQj6l3KC $DB
Deutsche Bank AG Increases #MRK & Co. Price Target to $59.00. Read more: https://t.co/ndMQ0i3oln $MRK
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/2glQ5MXtNL $DB
#DeutscheBankAG Increases MRK & Co. (MRK) Price Target to $59.00. Read more: https://t.co/1a3bR5NjVe $DB
@MRKManualPro Thank u very much. I love MRK Manuals--all nurses do! Gloria Poole,RN,artist; Missouri
US clears MRK’s Keytruda for head and neck cancer - PharmaTimes https://t.co/9gRwXQRBqE
MRK (MRK) Announces FDA Approval of KEYTRUDA as HNSCC Treatment https://t.co/yCjK0MWaHs via @Street_Insider
#Pharmaceuticals CONCOR : Tablet, film coated : 10mg : MRK KGaA, Germany : https://t.co/RoZ5UFwqR5 #MarketResearch #Statistics #mrx
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/xWAmgxMNwT
A lesson in personalized medicine
BMS #Opdivo failure vs MRK #Keytruda success, patients with 5% vs 50% PDL1 expsn https://t.co/6zz1Yv5x3G
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycAIQt via @investadvocate
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #biologyjobs https://t.co/lDzF9HfIdA
Associate Director MR and Analytics – Global Oncology Job - Gwynedd, PA, US - MRK #molecularbiologyjobs https://t.co/g90vpdnH5d
The MRK Veterinary Manual by Merial Limited, MRK & Co and Susan E. Aiello... https://t.co/HNHfvHXmtw https://t.co/1lW8CmeN0H
MRK 63.11 MRK & Company $MRK added to my watch list. Right now with MRK I am watching the last price 63.11 H https://t.co/VH9rYEiaas
MRK More than a Mother supports Jackline Mwende - a Victim of Infertility Stigma in Kenya https://t.co/TzU1ZnQFS3
“MRK More than a Mother” supports Jackline a Victim of Infertility Stigma in Kenya | https://t.co/NY1Uh6AITb https://t.co/eXHJfWVslr
The National Vaccine Information Center says MRK’s shingles vaccine may also be linked with fatalities.     rmatthews@dmlawfirm.com
The vaccination warnings for these adverse outcomes may insufficiently alert the patients MRK targets for its shingles shot.
One Put, One Call Option To Know About for MRK & Co.: Consistently, one of the more popular stocks ... https://t.co/KxrHoR7L7l #pharma
That is a woeful % by any stretch, given risks of any vaccination, but MRK’s shingles shot is also suspected to cause the...
MRK reports that its Zostavax shingles vaccine protects about 51 percent of the people shot with it.
Opdivo bet backfires, creates opening for MRK to pursue DTC https://t.co/RZoqMpr6kn
Unusual Healthcare Volume Gainers In Focus- Aratana Therapeutics (NASDAQ:PETX), MRK ...: Sunday bloom on Ar... https://t.co/v0WwGhF1Zh
Job Offer: Senior Process Engineer - Chemical: A senior engineer will act as lead process engineer on MRK n... https://t.co/zCSxJ2Z8GH
MRK Supports Jackline Mwende Infertility Stigma Victim in Kenya https://t.co/eU39ycSjI1 https://t.co/oaWTtrSWgM
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/iU9LNI8f1T $MRK #MRK
'MRK More than a Mother' to provide for Jackline Mwende with a monthly income of $250 and establish for her a sustainable business.
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/mmdcrGnRuw
“MRK More than a Mother” supports Jackline Mwend... https://t.co/kubWcBKejb #Marketing #AfricaRising #BrandArena
Credit Suisse downgrades Bristol-Myers to Neutral with $63 PT, upgrades MRK to Outperform with $73 PT
https://t.co/yVubdlxysb $BMY $MRK
#MRK locks up another #cancer approval for #Keytruda https://t.co/5iMXdnPjtQ
.@US_FDA approves @MRK's #Keytruda drug for head and neck #cancer treatment https://t.co/TyNJJfsF7G #Health #Pharma
Bristol-myers clobbered—shares drop 17%—after failed drug test #news #market #business https://t.co/QlYJCIcSrF https://t.co/nrjrJXFXBs
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/cmtnwfsCnN
MRK  & Co.'s PT raised by Deutsche Bank AG to $59.00. hold rating. https://t.co/vFsUZdd35x $MRK #MRK
@MRK_Engage gold already!
Check out MRK - Old World Christmas - Wooden Smoking Man  https://t.co/0FC8g7SBDd via @eBay
Bristol-Meyers Squibb's #LungCancer med Opdivo fails to meet goals for use as first-line treatment. #Pharma https://t.co/7tfD6zfIb4
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/YLxFkJSg5K $BMY
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer | FiercePharma -  https://t.co/WZgb2NA7Pb
Global Monoclonal Antibodies Market Growth of 9.84% CAGR by 2020 https://t.co/znpKEscJMo #antibody #mAb #lifescience #biotech #biopharma
@aliboo719 @doritmi @dkegel @MRY_ivy @vaxchoiceeast @joegooding @itsmepanda1 MRK the only company that commits genocide and gets away with
#BristolMyersSquibb Opdivo bet backfires, creates opening for MRK to pursue DTC . Read more: https://t.co/2ZFS8uCrGA $BMY
FYI #SciComm job .@EMDSerono (#biopharm division of MRK KGaA) seeks "Assoc Dir, Corp Communications"(Pos# 42570) ~ https://t.co/2GAnYai4Mu
Another win for patients with head and neck or lung #cancer, let the progress continue! https://t.co/xy8Exef0Sz
BMS loses its lung cancer lead to MRK as Opdivo data comes up short https://t.co/CWuor4DrT6
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/iUOiuL4UAc
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/AWDpr3l5wB
Priceline trade offers a 4% return in 74 days, or find similar option trades on Marathon Oil Corporation, Sears .. https://t.co/6NxDIZ7Rl1
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further -- https://t.co/zcJYo9PTvA: https://t.co/1cSkcfYtZB
Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening Further https://t.co/YyrsqswumQ #stocks
$BMY:

Why Credit Suisse Sees MRK and Bristol-Myers Gap Widening …:

https://t.co/nBTnC40aKU
Today’s #MedalChallenge: Daily physical activity
30+ mins = Gold
20 = Silver
10 = Bronze
How'd you do? Let us know! https://t.co/8eqJKAgCKd
@drmandark @abbvie @MRK @rdivia no money ?
MRK's Keytruda wins a double-header with new FDA approval in head-and-neck cancer https://t.co/YpsPlqZFM3
Get the facts on head and neck cancer: https://t.co/xiD9KVkDqL #hncsm
#Job #Stellenangebot https://t.co/vDlWFO8Jfi - MRK Group: Postdoctoral researcher for predictive models in drug design (m/f)
CORRECTED-BRIEF-MRK & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5) … https://t.co/RPTIY87mlG
#MRK & Co. PT Raised to $57.00. Read more: https://t.co/PwuB12Mcsu $MRK
